Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of 14C-Acoziborole in Healthy Men
NCT04270981Phase 1Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Feb 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of acoziborole in African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Primary endpoint: Total radioactivity in urines and feces at 121 days. Started Feb 2020; status: completed.
02
Drugs
acoziborole
03
Conditions
African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT04270981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270981.